Endo International Financial Statements (ENDP)
|
|
Report date
|
|
|
27.02.2018 |
28.02.2019 |
26.02.2020 |
26.02.2021 |
01.03.2022 |
|
09.08.2022 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
3 469 |
2 947 |
2 914 |
2 903 |
2 993 |
|
2 783 |
Operating Income, bln rub |
|
|
-960.1 |
-469.1 |
581.9 |
603.2 |
15.8 |
|
-1 863 |
EBITDA, bln rub |
? |
|
-807.3 |
250.0 |
764.6 |
473.0 |
472.8 |
|
-1 831 |
Net profit, bln rub |
? |
|
-2 035 |
-1 031 |
-422.6 |
183.9 |
-569.1 |
|
-2 585 |
|
OCF, bln rub |
? |
|
554.0 |
267.3 |
98.1 |
397.4 |
411.1 |
|
213.6 |
CAPEX, bln rub |
? |
|
125.7 |
86.4 |
63.9 |
721.5 |
77.9 |
|
81.6 |
FCF, bln rub |
? |
|
428.3 |
180.9 |
34.2 |
-324.1 |
333.1 |
|
131.9 |
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
OPEX, bln rub |
|
|
801.9 |
831.9 |
763.2 |
857.4 |
1 010 |
|
1 055 |
Cost of production, bln rub |
|
|
2 229 |
1 632 |
1 569 |
1 443 |
1 221 |
|
1 134 |
R&D, bln rub |
|
|
172.1 |
185.8 |
130.7 |
158.9 |
148.6 |
|
150.1 |
Interest expenses, bln rub |
|
|
494.7 |
534.9 |
558.7 |
537.1 |
562.4 |
|
561.4 |
|
Assets, bln rub |
|
|
11 636 |
10 132 |
9 390 |
9 265 |
8 767 |
|
6 362 |
Net Assets, bln rub |
? |
|
484.9 |
-498.3 |
-866.5 |
-647.9 |
-1 244 |
|
-2 899 |
Debt, bln rub |
|
|
8 276 |
8 258 |
8 405 |
8 326 |
8 082 |
|
8 105 |
Cash, bln rub |
|
|
986.6 |
1 149 |
1 455 |
1 213 |
1 507 |
|
1 192 |
Net debt, bln rub |
|
|
7 290 |
7 109 |
6 950 |
7 113 |
6 575 |
|
6 914 |
|
Ordinary share price, rub |
|
|
7.75 |
7.30 |
4.69 |
7.18 |
3.76 |
|
0.100 |
Number of ordinary shares, mln |
|
|
223.2 |
224.0 |
226.1 |
233.7 |
232.8 |
|
235.1 |
|
Market cap, bln rub |
|
|
1 730 |
1 635 |
1 060 |
1 678 |
875 |
|
24 |
EV, bln rub |
? |
|
9 019 |
8 744 |
8 010 |
8 791 |
7 450 |
|
6 937 |
Book value, bln rub |
|
|
-8 283 |
-7 720 |
-7 033 |
-6 949 |
-6 804 |
|
-6 481 |
|
EPS, rub |
? |
|
-9.12 |
-4.61 |
-1.87 |
0.79 |
-2.44 |
|
-11.0 |
FCF/share, rub |
|
|
1.92 |
0.81 |
0.15 |
-1.39 |
1.43 |
|
0.56 |
BV/share, rub |
|
|
-37.1 |
-34.5 |
-31.1 |
-29.7 |
-29.2 |
|
-27.6 |
|
EBITDA margin, % |
? |
|
-23.3% |
8.48% |
26.2% |
16.3% |
15.8% |
|
-65.8% |
Net margin, % |
? |
|
-58.7% |
-35.0% |
-14.5% |
6.34% |
-19.0% |
|
-92.9% |
FCF yield, % |
? |
|
24.8% |
11.1% |
3.23% |
-19.3% |
38.1% |
|
561.0% |
ROE, % |
? |
|
-419.8% |
207.0% |
48.8% |
-28.4% |
45.7% |
|
89.2% |
ROA, % |
? |
|
-17.5% |
-10.2% |
-4.50% |
1.99% |
-6.49% |
|
-40.6% |
|
P/E |
? |
|
-0.85 |
-1.59 |
-2.51 |
9.12 |
-1.54 |
|
-0.01 |
P/FCF |
|
|
4.04 |
9.04 |
31.0 |
-5.18 |
2.63 |
|
0.18 |
P/S |
? |
|
0.50 |
0.55 |
0.36 |
0.58 |
0.29 |
|
0.01 |
P/BV |
? |
|
-0.21 |
-0.21 |
-0.15 |
-0.24 |
-0.13 |
|
0.00 |
EV/EBITDA |
? |
|
-11.2 |
35.0 |
10.5 |
18.6 |
15.8 |
|
-3.79 |
Debt/EBITDA |
|
|
-9.03 |
28.4 |
9.09 |
15.0 |
13.9 |
|
-3.78 |
|
R&D/CAPEX, % |
|
|
136.9% |
215.1% |
204.7% |
22.0% |
190.6% |
|
183.8% |
|
CAPEX/Revenue, % |
|
|
3.62% |
2.93% |
2.19% |
24.9% |
2.60% |
|
2.93% |
|
Endo International shareholders |